Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06595602

Intelligent Lung Support in the Intensive Care Unit

Intelligent Lung Support in the Intensive Care Unit (IntelliLung): An Observational, Prospective, Multicentre Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
530 (estimated)
Sponsor
Technische Universität Dresden · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this observational study is to test the IntelliLung decision support system based on artificial intelligence. This system is intended to help to set the ventilator. The study includes patients with and without ARDS (acute respiratory distress syndrome) who are receiving invasive mechanical ventilation, as well as patients with additional extracorporeal lung support. The study will be conducted in several centers. The main question of the study: How well do the mechanical ventilation settings of healthcare staff match the recommendations of the IntelliLung system?

Conditions

Interventions

TypeNameDescription
DEVICEArtificial intelligence based decision support system (AI-DSS); softwareThe device is intended for monitoring and recommending ventilator settings, ventilation mode to qualified Intensive Care Unit (ICU) health care professionals (HCP). This is for medical indications that require invasive mechanical ventilation of the respiratory system in the ICU under international / EU guidelines. The device receives clinical data via the ICU's data integration platform that includes patient physical and demographic data as well as current vital signs, ventilation parameters, blood gas analysis, general blood laboratory reports, fluid balance and medication. Prediction models based on artificial intelligence algorithms are used to deduce therapy suggestions from received data. The algorithm is carried out on a secured cloud platform.

Timeline

Start date
2025-05-25
Primary completion
2027-12-01
Completion
2027-12-01
First posted
2024-09-19
Last updated
2026-04-17

Locations

5 sites across 4 countries: Germany, Italy, Poland, Spain

Source: ClinicalTrials.gov record NCT06595602. Inclusion in this directory is not an endorsement.